newmediawire

Kaplan Fox & Kilsheimer LLP Reminds Investors of a Securities Class Action Against Duolingo, Inc. (NASDAQ: DUOL) and Lead Plaintiff Deadline on December 7, 2026

Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Duolingo, Inc. (“Duolingo” or the ...
newmediawire

Kaplan Fox Notifies DICK's Sporting Goods, Inc. (NYSE: DKS) Investors of a Pending Securities Class Action Deadline on November 3, 2026

Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against DICK’s Sporting Goods, Inc. (“Dick’s ...
newmediawire

INVESTOR DEADLINE ALERT: Compass, Inc. (COMP) Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Kessler Topaz Meltzer & Check, LLP

Are you a former Anywhere Real Estate Inc. shareholder who exchanged your shares of Anywhere stock for Compass, Inc. common ...
newmediawire

Kaplan Fox Class Action Reminder: Duolingo, Inc. (NASDAQ: DUOL) Lead Plaintiff Deadline is December 7, 2026

Kilsheimer LLP announces that a class action lawsuit has been filed against Duolingo, Inc. (“Duolingo” or the “Company”) ...
newmediawire

Nano-X Imaging (NNOX) Advances Its Mission to Expand Access to Medical Imaging

Nanox is working to make advanced medical imaging more accessible through digital 3D tomosynthesis technology designed to ...
newmediawire

PXG Unveils the Next Evolution of Its Secret Weapon Mini Driver

A Thinner Face and Optimized Weighting Advance Speed, Forgiveness, and Control off the Tee or Turf SCOTTSDALE, AZ - October ...
newmediawire

Kaplan Fox Encourages Investors of Gildan Activewear Inc. (NYSE: GIL) to Contact the Firm to Learn About Their Legal Rights

Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Gildan Activewear Inc. (“Gildan” or ...
newmediawire

Neovii Advances FDA Fast Track-Designated ATLG Program in Type 1 Diabetes With Pivotal Phase 2 Study - Company Appoints Physician-scientist Salvatore Alesci as Chief Medical ...

Neovii Pharmaceuticals AG, a Swiss-headquartered, commercial-stage biopharmaceutical company with more than four decades of experience in antibody-based immunotherapies, today announced that it is ...
newmediawire

naoo Completes Kingfluencers Integration and Sets the Stage for Its Next Phase of Growth

Shared Zurich office, integrated functions and new growth initiatives lay the foundation for the next phase of collaboration ZUG and ZURICH, SWITZERLAND - October (NEWMEDIAWIRE) - naoo AG (Dusseldorf: ...